Platelet function and antithrombins in hyperlipoproteinemia type IIa

Platelet function was studied in 35 patients with type IIa hyperlipoproteinemia and 22 normal controls. Platelet aggregation by ADP in concentrations ranging from 2×10-6 to 2×10-5 M, and adrenaline 10-6 M were similar in both groups. In contrast, aggregation induced by collagen and secondary aggrega...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Molinas, F.C., Drucker, E., Kordich, L., Alvarez Reynolds, M., Finkielman, S.
Formato: JOUR
Materias:
Acceso en línea:http://hdl.handle.net/20.500.12110/paper_00493848_v22_n4_p427_Molinas
Aporte de:
id todo:paper_00493848_v22_n4_p427_Molinas
record_format dspace
spelling todo:paper_00493848_v22_n4_p427_Molinas2023-10-03T14:52:38Z Platelet function and antithrombins in hyperlipoproteinemia type IIa Molinas, F.C. Drucker, E. Kordich, L. Alvarez Reynolds, M. Finkielman, S. antithrombins hyperlipoproteinemia platelet aggregation antithrombin cholesterol heparin blood and hemopoietic system etiology human cell hyperlipoproteinemia type 2a in vitro study thrombocyte aggregation Adenosine Diphosphate Adult Antithrombins Blood Coagulation Blood Platelets Calcium Cholesterol Epinephrine Female Heparin Antagonists Humans Hyperlipoproteinemia Type II Male Middle Aged Platelet Aggregation Thromboplastin Platelet function was studied in 35 patients with type IIa hyperlipoproteinemia and 22 normal controls. Platelet aggregation by ADP in concentrations ranging from 2×10-6 to 2×10-5 M, and adrenaline 10-6 M were similar in both groups. In contrast, aggregation induced by collagen and secondary aggregation elicited by bovine factor VIII were significantly lower in hypercholesterolemic patients, who also disclosed an increased plasmatic antiheparin activity. This plasmatic antiheparin activity was inversely correlated to plasmatic cholesterol concentration, (r = -0.50, p<0.01). PF3 and PF4 were normal in patients with type IIa hyperlipoproteinemia. AntiFXa, antithrombin III, and heparin cofactor were also determined. Heparin cofactor was found to be significantly lower in hypercholesterolemic patients than in controls, and inversely correlated to plasmatic cholesterol concentration (r = -0.51, p<0.05). These observations suggest that the thrombotic tendency in hypercholesterolemia may be related to a decrease of plasmatic heparin cofactor. © 1981. Fil:Kordich, L. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_00493848_v22_n4_p427_Molinas
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic antithrombins
hyperlipoproteinemia
platelet aggregation
antithrombin
cholesterol
heparin
blood and hemopoietic system
etiology
human cell
hyperlipoproteinemia type 2a
in vitro study
thrombocyte aggregation
Adenosine Diphosphate
Adult
Antithrombins
Blood Coagulation
Blood Platelets
Calcium
Cholesterol
Epinephrine
Female
Heparin Antagonists
Humans
Hyperlipoproteinemia Type II
Male
Middle Aged
Platelet Aggregation
Thromboplastin
spellingShingle antithrombins
hyperlipoproteinemia
platelet aggregation
antithrombin
cholesterol
heparin
blood and hemopoietic system
etiology
human cell
hyperlipoproteinemia type 2a
in vitro study
thrombocyte aggregation
Adenosine Diphosphate
Adult
Antithrombins
Blood Coagulation
Blood Platelets
Calcium
Cholesterol
Epinephrine
Female
Heparin Antagonists
Humans
Hyperlipoproteinemia Type II
Male
Middle Aged
Platelet Aggregation
Thromboplastin
Molinas, F.C.
Drucker, E.
Kordich, L.
Alvarez Reynolds, M.
Finkielman, S.
Platelet function and antithrombins in hyperlipoproteinemia type IIa
topic_facet antithrombins
hyperlipoproteinemia
platelet aggregation
antithrombin
cholesterol
heparin
blood and hemopoietic system
etiology
human cell
hyperlipoproteinemia type 2a
in vitro study
thrombocyte aggregation
Adenosine Diphosphate
Adult
Antithrombins
Blood Coagulation
Blood Platelets
Calcium
Cholesterol
Epinephrine
Female
Heparin Antagonists
Humans
Hyperlipoproteinemia Type II
Male
Middle Aged
Platelet Aggregation
Thromboplastin
description Platelet function was studied in 35 patients with type IIa hyperlipoproteinemia and 22 normal controls. Platelet aggregation by ADP in concentrations ranging from 2×10-6 to 2×10-5 M, and adrenaline 10-6 M were similar in both groups. In contrast, aggregation induced by collagen and secondary aggregation elicited by bovine factor VIII were significantly lower in hypercholesterolemic patients, who also disclosed an increased plasmatic antiheparin activity. This plasmatic antiheparin activity was inversely correlated to plasmatic cholesterol concentration, (r = -0.50, p<0.01). PF3 and PF4 were normal in patients with type IIa hyperlipoproteinemia. AntiFXa, antithrombin III, and heparin cofactor were also determined. Heparin cofactor was found to be significantly lower in hypercholesterolemic patients than in controls, and inversely correlated to plasmatic cholesterol concentration (r = -0.51, p<0.05). These observations suggest that the thrombotic tendency in hypercholesterolemia may be related to a decrease of plasmatic heparin cofactor. © 1981.
format JOUR
author Molinas, F.C.
Drucker, E.
Kordich, L.
Alvarez Reynolds, M.
Finkielman, S.
author_facet Molinas, F.C.
Drucker, E.
Kordich, L.
Alvarez Reynolds, M.
Finkielman, S.
author_sort Molinas, F.C.
title Platelet function and antithrombins in hyperlipoproteinemia type IIa
title_short Platelet function and antithrombins in hyperlipoproteinemia type IIa
title_full Platelet function and antithrombins in hyperlipoproteinemia type IIa
title_fullStr Platelet function and antithrombins in hyperlipoproteinemia type IIa
title_full_unstemmed Platelet function and antithrombins in hyperlipoproteinemia type IIa
title_sort platelet function and antithrombins in hyperlipoproteinemia type iia
url http://hdl.handle.net/20.500.12110/paper_00493848_v22_n4_p427_Molinas
work_keys_str_mv AT molinasfc plateletfunctionandantithrombinsinhyperlipoproteinemiatypeiia
AT druckere plateletfunctionandantithrombinsinhyperlipoproteinemiatypeiia
AT kordichl plateletfunctionandantithrombinsinhyperlipoproteinemiatypeiia
AT alvarezreynoldsm plateletfunctionandantithrombinsinhyperlipoproteinemiatypeiia
AT finkielmans plateletfunctionandantithrombinsinhyperlipoproteinemiatypeiia
_version_ 1807322220042649600